Authors:
BOSSERHOFF AK
HEIN R
STOLZ W
KAUFMANN M
KALUZA B
LANDTHALER M
BUETTNER R
Citation: Ak. Bosserhoff et al., MIA, A SERUM MARKER FOR THERAPY MONITORING OF MALIGNANT-MELANOMA, Journal of investigative dermatology, 110(4), 1998, pp. 717-717
Authors:
HEIN R
BOSSERHOFF AK
STOLZ W
KAUFMANN M
KALUZA B
BUETTNER R
Citation: R. Hein et al., MIA, A NOVEL SERUM MARKER FOR STAGING AND MONITORING MALIGNANT-MELANOMA, Journal of investigative dermatology, 109(3), 1997, pp. 408-408
Authors:
BOSSERHOFF AK
KAUFMANN M
KALUZA B
BARTKE I
ZIRNGIBL H
HEIN R
STOLZ W
BUETTNER R
Citation: Ak. Bosserhoff et al., MELANOMA-INHIBITING ACTIVITY, A NOVEL SERUM MARKER FOR PROGRESSION OFMALIGNANT-MELANOMA, Cancer research, 57(15), 1997, pp. 3149-3153
Citation: M. Schmidt et al., CORRELATION BETWEEN THE STABILITY OF THE GROEL-PROTEIN LIGAND COMPLEXAND THE RELEASE MECHANISM, The Journal of biological chemistry, 269(45), 1994, pp. 27964-27972
Authors:
DENEVE M
DELOOSE M
JACOBS A
VANHOUDT H
KALUZA B
WEIDLE U
VANMONTAGU M
DEPICKER A
Citation: M. Deneve et al., ASSEMBLY OF AN ANTIBODY AND ITS DERIVED ANTIBODY FRAGMENT IN NICOTIANA AND ARABIDOPSIS, Transgenic research, 2(4), 1993, pp. 227-237
Authors:
FRANCOIS C
BOEFFARD F
KALUZA B
WEIDLE UH
JACQUES Y
Citation: C. Francois et al., CONSTRUCTION OF A BISPECIFIC ANTIBODY REACTING WITH THE ALPHA-CHAIN AND BETA-CHAIN OF THE HUMAN IL-2 RECEPTOR - HIGH-AFFINITY CROSS-LINKINGAND HIGH ANTIPROLIFERATIVE EFFICIENCY, The Journal of immunology, 150(10), 1993, pp. 4610-4619